Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease

Immunol Allergy Clin North Am. 2016 Nov;36(4):657-668. doi: 10.1016/j.iac.2016.06.003. Epub 2016 Sep 13.

Abstract

Aspirin-exacerbated respiratory disease (AERD) is a distinct clinical condition characterized by chronic sinusitis with nasal polyps, asthma, and hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs). Distinguishing AERD from other forms of chronic sinusitis, asthma, and NSAID reactivity has important clinical implications for management. The clinical history is helpful, but not adequate for confirming the diagnosis of AERD, in most cases. Diagnostic provocation challenge remains the only way to confirm or exclude the diagnosis of AERD. This article discusses the utility of the clinical history and the current evidence regarding measures that optimize the safety of performing diagnostic NSAID provocation challenges.

Keywords: Aspirin-exacerbated respiratory disease; Asthma; Chronic rhinosinusitis with nasal polyps; Diagnosis; Intranasal ketorolac; Lysine-aspirin; NSAID hypersensitivity; Oral aspirin challenge.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Aspirin / adverse effects*
  • Bronchial Provocation Tests
  • Humans
  • Nasal Provocation Tests
  • Phenotype
  • Respiratory Function Tests
  • Respiratory Tract Diseases / diagnosis*
  • Respiratory Tract Diseases / etiology*
  • Respiratory Tract Diseases / therapy
  • Sensitivity and Specificity

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin